Liver iron accumulation in patients with chronic active hepatitis C: Prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions

Journal of Hepatology

Volumn 31, Issue 6, 1999, Pages 979-984

  Hézode, Christophe ^b   Cazeneuve, Cécile ^b   Coué, Oliver ^c   Roudot Thoraval, Francçoise ^c   Lonjon, Isabelle ^c   Bastie, Anne ^c   Duvoux, Christophe ^c   Pawlotsky, Jean Michel ^a   Zafrani, Elie Serge ^c   Amselem, Serge ^c   Dhumeaux, Daniel ^c  

^a HENRI MONDOR HOSPITAL   (France)

^b Serv d'Hepatologie G   (France)

^c NONE

Author keywords

Chronic hepatitis; Cirrhosis; Hepatitis C virus; HFE gene; Liver iron accumulation

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHRONIC ACTIVE HEPATITIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FIBROSIS; GENE FREQUENCY; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL;

EID: 0344129013     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80308-0     Document Type: Article

References (26)

1. Bonkovsky HL, Banner BF, Rothman L. Iron and chronic viral hepatitis. Hepatology. 25:1997;759-768.
2. Boucher E, Bourienne A, Adams P, Turlin B, Brissot P, Deugnier Y. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut. 41:1997;115-120.
3. Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology. 108:1995;1104-1109.
4. Barton AL, Banner BF, Cable EE, Bonkovsky HL. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol. 103:1995;419-424.
5. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS. Response to interferon α therapy is influenced by the iron content of the liver. J Hepatol. 20:1994;410-415.
6. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
7. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, et al. Haemochromatosis and HLA-H. Nat Genet. 14:1996;249-251.
8. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Mosser J, et al. Haemochromatosis and HLA-H. Nat Genet. 14:1996;251-252.
9. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, et al. Mutation analysis in hereditary haemochromatosis. Blood Cells Mol Dis. 22:1996;187-194.
10. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic haemochromatosis: evolution of diagnostic criteria. Gastroenterology. 114:1998;319-323.
11. Beutier E. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet. 349:1997;296-297.
12. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis C282Y mutation in sporadic porphyria cutanea tarda. Lancet. 349:1997;321-323.
13. George DK, Goldwurm S, Macdonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology. 114:1998;311-318.
14. Intraobserver and interobserver variation in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 20:1994;15-20.
15. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 24:1996;289-293.
16. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med. 335:1996;1799-1805.
17. Moirand R, Mortaji A, Loréal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet. 349:1997;95-97.
18. Deugnier Y, Moirand R, Jouanolle AM, Le Gall JY, Brissot P, David V. HLA-H mutations in patients with iron overload and normal transferrin saturation. Hepatology. 26:1997;199A.
19. Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology. 27:1998;1695-1699.
20. Deugnier Y, Turlin B, Le Quilleuc D, Moirand R, Loréal O, Messner M, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of haemochromatosis. Am J Surg Pathol. 21:1997;669-675.
21. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology. 112:1997;882-888.
22. Brissot P, Wright T, Ma W, Weisiger R. Efficient clearance of non-transferrin bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J Clin Invest. 76:1987;1463-1470.
23. Koff RS, Go TB, Oliai A. Hepatic hemosiderosis after portacaval shunting: a sometime thing. Gastroenterology. 63:1972;834-836.
24. Baker JA, Cohen M. Development of hemosiderosis after side-to-side portacaval shunting. Gastroenterology. 63:1972;491-494.
25. Capron JP, Remond A, Dupas JL, Mancheron H, Capron-Chivrac D, Braillon A. Hepatic hemosiderosis in extrahepatic portal obstruction. Role of spontaneous portosystemic shunting? Dig Dis Sci. 31:1986;889-892.
26. Arber N, Konikoff FM, Moshkowitz M, Baratz M, Hallak A, Santo M, et al. Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig Dis Sci. 39:1994;2656-2659.